Literature DB >> 21429028

Mid-term prognosis after endoscopic resection for submucosal colorectal carcinoma: summary of a multicenter questionnaire survey conducted by the colorectal endoscopic resection standardization implementation working group in Japanese Society for Cancer of the Colon and Rectum.

Shiro Oka1, Shinji Tanaka, Hiroyuki Kanao, Hideki Ishikawa, Toshiaki Watanabe, Masahiro Igarashi, Yutaka Saito, Hiroaki Ikematsu, Kiyonori Kobayashi, Yuji Inoue, Naohisa Yahagi, Sumio Tsuda, Seiji Simizu, Hiroyasu Iishi, Hiroo Yamano, Shin-ei Kudo, Osamu Tsuruta, Satoshi Tamura, Yusuke Saito, Eisai Cho, Takahiro Fujii, Yasushi Sano, Hisashi Nakamura, Kenichi Sugihara, Tetsuichiro Muto.   

Abstract

We carried out a retrospective questionnaire survey of 792 submucosal colorectal carcinoma (CRC) cases from 15 institutions affiliated with the Colorectal Endoscopic Resection Standardization Implementation Working Group in Japanese Society for Cancer of the Colon and Rectum. In these cases, endoscopic resection (ER) and surveillance was carried out without additional surgical resection. Local recurrence or metastasis was observed in 18 cases. Local submucosal recurrence was observed in 11 cases, and metastatic recurrence was observed in 13 cases. Among the 15 cases in which the depth of submucosal invasion was measured, two cases showed depth less than 1000 µm, which has other risk factors for metastasis. Metastatic recurrence was observed in the lung, liver, lymph node, bone, adrenal glands, and the brain; in some cases, metastatic recurrence was observed in multiple organs. Death due to primary disease was observed in six cases. The average interval between ER and recurrence was 19.7 ± 9.2 months. In 16 cases, recurrence was observed within 3 years after ER. Thus, validity of ER without additional surgical resection for cases with the conditions that the depth of submucosal invasion is less than 1000 µm and the histological grade is well or moderately differentiated adenocarcinoma with no lymphatic and venous involvement was proven.
© 2011 The Authors. Digestive Endoscopy © 2011 Japan Gastroenterological Endoscopy Society.

Entities:  

Mesh:

Year:  2011        PMID: 21429028     DOI: 10.1111/j.1443-1661.2010.01072.x

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  19 in total

1.  Long-term outcomes after treatment for T1 colorectal carcinoma.

Authors:  Naoki Asayama; Shiro Oka; Shinji Tanaka; Yuki Ninomiya; Yuzuru Tamaru; Kenjiro Shigita; Nana Hayashi; Hiroyuki Egi; Takao Hinoi; Hideki Ohdan; Koji Arihiro; Kazuaki Chayama
Journal:  Int J Colorectal Dis       Date:  2015-12-22       Impact factor: 2.571

2.  Importance of histological evaluation in endoscopic resection of early colorectal cancer.

Authors:  Naohisa Yoshida; Yuji Naito; Nobuaki Yagi; Akio Yanagisawa
Journal:  World J Gastrointest Pathophysiol       Date:  2012-04-15

3.  Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group.

Authors:  Yuzuru Tamaru; Shiro Oka; Shinji Tanaka; Shinji Nagata; Yuko Hiraga; Toshio Kuwai; Akira Furudoi; Tadamasa Tamura; Masaki Kunihiro; Hideharu Okanobu; Koichi Nakadoi; Hiroyuki Kanao; Makoto Higashiyama; Koji Arihiro; Kazuya Kuraoka; Fumio Shimamoto; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2017-02-13       Impact factor: 7.527

4.  Recurrent colorectal cancer after endoscopic resection when additional surgery was recommended.

Authors:  Yukiko Takatsu; Yosuke Fukunaga; Shunsuke Hamasaki; Atsushi Ogura; Jun Nagata; Toshiya Nagasaki; Takashi Akiyoshi; Tsuyoshi Konishi; Yoshiya Fujimoto; Satoshi Nagayama; Masashi Ueno
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

5.  Endoscopic treatment for high-risk T1 colorectal cancer: is it better to begin with endoscopic or surgical treatment?

Authors:  Shintaro Fujihara; Hirohito Mori; Hideki Kobara; Noriko Nishiyama; Akira Yoshitake; Akihiro Deguchi; Tsutomu Masaki
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-04

6.  Evidence-based clinical practice guidelines for management of colorectal polyps.

Authors:  Shinji Tanaka; Yusuke Saitoh; Takahisa Matsuda; Masahiro Igarashi; Takayuki Matsumoto; Yasushi Iwao; Yasumoto Suzuki; Hiroshi Nishida; Toshiaki Watanabe; Tamotsu Sugai; Ken-Ichi Sugihara; Osamu Tsuruta; Ichiro Hirata; Nobuo Hiwatashi; Hiroshi Saito; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-07       Impact factor: 7.527

Review 7.  Endoscopic resection for gastrointestinal tumors (esophageal, gastric, colorectal tumors): Japanese standard and future prospects.

Authors:  Yuka Yanai; Chizu Yokoi; Kazuhiro Watanabe; Naoki Akazawa; Junichi Akiyama
Journal:  Glob Health Med       Date:  2021-12-31

8.  Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma.

Authors:  Koichi Nakadoi; Shiro Oka; Shinji Tanaka; Nana Hayashi; Motomi Terasaki; Koji Arihiro; Fumio Shimamoto; Kazuaki Chayama
Journal:  Surg Endosc       Date:  2013-11-27       Impact factor: 4.584

9.  Long-term outcomes after treatment for pedunculated-type T1 colorectal carcinoma: a multicenter retrospective cohort study.

Authors:  Naoki Asayama; Shiro Oka; Shinji Tanaka; Shinji Nagata; Akira Furudoi; Toshio Kuwai; Seiji Onogawa; Tadamasa Tamura; Hiroyuki Kanao; Yuko Hiraga; Hideharu Okanobu; Takayasu Kuwabara; Masaki Kunihiro; Shinichi Mukai; Eizo Goto; Fumio Shimamoto; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2015-11-16       Impact factor: 7.527

10.  Risk factors of recurrence in T1 colorectal cancers treated by endoscopic resection alone or surgical resection with lymph node dissection.

Authors:  Yuta Kouyama; Shin-Ei Kudo; Hideyuki Miyachi; Katsuro Ichimasa; Shingo Matsudaira; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Takemasa Hayashi; Kunihiko Wakamura; Fumio Ishida; Shigeharu Hamatani
Journal:  Int J Colorectal Dis       Date:  2018-05-11       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.